Menu
SOPHiA GENETICSTM is excited to be a part of the Association of Molecular Pathology 2022 annual meeting, held in person in Phoenix, Arizona from November 1-5.
You will have the chance to chat with our experts at booth #1120 and demo the universal SOPHiA DDM™ Platform.
Accelerating NGS Workflows in Oncology Clinical Research: From Genomic Data to Insights
Corporate Workshop Day November 2
1:00-1:50pm
Room 228AB
Presented by:
Dr. Adrien Buisson
Praticien Spécialiste des CLCC – UF de Biologie des Tumeurs, Centre Léon Bérard- Cheney
Next-generation sequencing (NGS) has the potential to revolutionize cancer care, but creates increasingly large and complex datasets for analysis. Without the right analytical technology, pinpointing causative variants and obtaining actionable insights from NGS data requires specialist skills, multiple resources, and considerable time. During this workshop, speakers will share their experience of overcoming the challenges of NGS and maximizing laboratory workflow efficiency with algorithm-powered solutions that offer high analytical performance, intuitive interpretation features, and flexible reporting. Join us to learn about how SOPHiA DDMTM can help your laboratory uncover genomic insights from solid tumor and hematology applications more quickly and confidently.
SOPHiA GENETICSTM products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
